You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase%20III%20study

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)

Not yet recruiting
  • Marburg Virus Disease
  • cAd3-Marburg vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Apr 17, 2023

Bladder Urothelial Carcinoma In Situ, Infiltrating Bladder Mixed Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Guam,

Recruiting
  • Bladder Urothelial Carcinoma In Situ
  • +4 more
  • Gemcitabine Hydrochloride
  • Pembrolizumab
  • Birmingham, Alabama
  • +379 more
Aug 23, 2022

Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Esophageal Cancer
  • (no location specified)
Jul 6, 2023

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

Primary Biliary Cholangitis Trial in Canada (Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Raltegravir, Placebo Oral Capsule

Recruiting
  • Primary Biliary Cholangitis
  • Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)
  • +2 more
  • Edmonton, Alberta, Canada
  • +5 more
Mar 15, 2022

Spinal Fusion, Spinal Stenosis Trial (Pulse width modulation)

Not yet recruiting
  • Spinal Fusion
  • Spinal Stenosis
  • Pulse width modulation
  • (no location specified)
Nov 1, 2023

TNBC Trial in Shanghai (PM8002, nab-paclitaxel)

Recruiting
  • TNBC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2023

Behavior Problems Trial in Quatre Bornes (Smartfish Omega, Smartfish Fruit Juice Only)

Recruiting
  • Behavior Problems
  • Smartfish Omega
  • Smartfish Fruit Juice Only
  • Quatre Bornes, Mauritius
    Joint Child Health Project
Jun 5, 2023

KAP Regarding Tuberculosis Among Physicians in Assiut City

Not yet recruiting
  • Tuberculosis
    • (no location specified)
    Apr 6, 2023

    Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

    Recruiting
    • Type 2 Diabetes
    • +2 more
    • San Antonio, Texas
      Texas Diabetes Institute
    Dec 22, 2021

    Autism Spectrum Disorder Trial in Phoenix (Wide-spectrum nutritional supplement, Placebo)

    Active, not recruiting
    • Autism Spectrum Disorder
    • Wide-spectrum nutritional supplement
    • Placebo
    • Phoenix, Arizona
      Southwestern Research & Resource Center
    Sep 26, 2022

    Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma Trial in

    Recruiting
    • Fallopian Tube Mucinous Adenocarcinoma
    • +49 more
    • Cediranib Maleate
    • +5 more
    • Anchorage, Alaska
    • +373 more
    Aug 17, 2022

    Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,

    Active, not recruiting
    • Inflammatory Breast Cancer
    • +9 more
    • Duarte, California
    • +1 more
    Jul 9, 2021

    Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)

    Active, not recruiting
    • Locally Advanced/Metastatic Solid Tumors
    • Shanghai, China
      复旦大学附属中山医院
    Mar 23, 2023

    Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder Trial in Duarte (Leflunomide)

    Active, not recruiting
    • Recurrent Lymphoproliferative Disorder
    • Refractory Lymphoproliferative Disorder
    • Duarte, California
      City of Hope Medical Center
    Jun 7, 2022

    Dental Decay, Periodontal Abscess, Periodontitis Trial in Hannonville sous les Côtes (Intra oral cameras)

    Recruiting
    • Dental Decay
    • +6 more
    • Intra oral cameras
    • Hannonville sous les Côtes, France
      EHPAD St Georges
    Jul 19, 2022

    NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +5 more
    • Autologous, engineered T Cells targeting TP53 R175H
    • Duarte, California
      City of Hope
    May 17, 2023

    Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)

    Active, not recruiting
    • Advanced Solid Tumor
    • Duarte, California
    • +9 more
    Nov 28, 2022

    Autoimmune Diseases, Multiple Sclerosis Trial in Amman (LPX-TI641)

    Not yet recruiting
    • Autoimmune Diseases
    • Multiple Sclerosis
    • Amman, Jordan
      Triumpharma
    May 11, 2023

    Heart Failure Trial in Malaga (MPP ON)

    Completed
    Has Results
    • Heart Failure
    • MPP ON
    • Malaga, Spain
      Hospital Virgen de la Victoria
    Feb 18, 2022

    Pregnancy Related, Hypertension Trial in Chapel Hill (Usual Care, ACHIEVE Multi-component Implementation Strategy)

    Not yet recruiting
    • Pregnancy Related
    • Hypertension
    • Usual Care
    • ACHIEVE Multi-component Implementation Strategy
    • Chapel Hill, North Carolina
      The University of North Carolina at Chapel Hill
    Aug 15, 2023

    Disfigurement of Face Trial in New York (Face recognition task)

    Enrolling by invitation
    • Disfigurement of Face
    • Face recognition task
    • New York, New York
      New York University School of Medicine
    Sep 7, 2022

    Prostate Cancer Trial in Rome (Decapeptyl)

    Recruiting
    • Prostate Cancer
    • Rome, Lazio, Italy
    • +2 more
    Sep 23, 2022

    Parkinson's Disease Trial in United States (VY-AADC02, Sham (Placebo) Surgery)

    Active, not recruiting
    • Parkinson's Disease
    • VY-AADC02
    • Sham (Placebo) Surgery
    • Irvine, California
    • +19 more
    Mar 17, 2022

    Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (autologous immunoglobulin

    Completed
    • Refractory Multiple Myeloma
    • +3 more
    • autologous immunoglobulin idiotype-KLH conjugate vaccine
    • +3 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    May 2, 2019